Recent Headlines
Within Pharmaceuticals
Podcast on Vitiligo with Recouleur® Vitiligo Vitamin Creator Audrey VanStockum
The podcast entitled “The Journey with Vitiligo with Audrey VanStockum,” will air August 31, 2021 at 11:00 a.m. CST and can be heard live as well as recorded after the show on Blog Talk Radio. VanStockum will discuss treatments she tried, and how she created Recouleur. - August 25, 2021 - Supernatural Health, Inc.
Omni Healthcare Communications & Res Consortium Form Alliance to Expand Medical Affairs Capabilities
Omni Healthcare Communications (Omni-HC), a US based medical communications firm delivering solutions for today’s scientific exchange challenges, is pleased to announce the formation of a strategic alliance with Res Consortium (Res) of the United Kingdom, a cross-sector leader in digital... - August 21, 2021 - Sunny Ayr Holdings
UpSpring® Launches New U.Siip Line of Water Enhancers for Moms
UpSpring LLC, maker of clinically-backed health and wellness solutions for all stages of mom-hood, today announced it has launched U.Siip Water Enhancers with 4 key electrolytes specifically formulated for women who are pregnant or breastfeeding. - August 19, 2021 - Upspring LLC
Macrosoft CCM Best Practices Survey Results 2021 – AI Users vs. Non-AI Users
This Part 2 of the survey results, takes a deeper dive into two sub-populations of respondents: those that ranked AI usage in their CCM program as already well established versus those that did not. - August 19, 2021 - Macrosoft Inc.
HCS Pharma Opens Representative Office in Taiwan and Joins National Health Research Institutes Incubator
Biotech startup HCS Pharmais entering into incubation at the prestigious NHRI (National Health Research Institutes) in Taiwan. There, it will develop collaborations to put its exclusive BIOMIMESYS® technology at the service of the country's four major scientific research institutions. HCS Pharma has also opened a representative office in Taiwan, headed by Joseph Chou. - August 19, 2021 - HCS Pharma
Riester Acquires PCP Stethoscopes from RNK - MobilDrTech Continues Stethoscope Sales & Expands Product Line
Rudolf Riester GmbH of Jungingen, Germany, has acquired PCP-USB and PCP-1 stethoscopes from RNK Products, Inc. The RNK PCP line of stethoscopes has been rebranded as ri-sonic® PCP stethoscopes and Riester has assumed manufacturing operations and distribution. MobilDrTech, Inc. is pleased to announce a business affiliation with Riester where MobilDrTech will continue marketing, sales and support for the ri-sonic® PCP stethoscopes as an authorized dealer for Riester. - August 10, 2021 - MobilDrTech, Inc.
Food is Medicinal: PRVZN CO Launches LUV Your Mood to Help Make Stress Less Stressful
To help people fight the negative effects of stress, global wellbeing company PRVZN CO LLC, a pioneer in the use of adaptogens, has launched LUV Your Mood. Its selection of ingredients utilizes a powerful blend of Ayurvedic medicine and modern research to create a naturally sound, science-backed supplement for its customers. The dietary supplement features nine adaptogens that support the body's ability to adapt to stress, combat fatigue, and improve mental clarity.* - August 10, 2021 - PRVZN CO LLC
Reverie Psychedelics and Indiana Health Group Partner to Develop World-Class Psychedelic Research Center
Reverie Psychedelics (Reverie), a leading and rapidly growing psychedelic – assisted psychotherapy clinic and research organization, has further expanded its footprint and capabilities by partnering with Indiana Health Group (IHG), the largest provider of psychiatric and mental health and... - August 05, 2021 - Reverie Psychedelics
Foxx Life Sciences Celebrates Major Expansion
Foxx Life Sciences celebrates two new manufacturing facilities in Londonderry, New Hampshire and Hyderabad, India. The new locations add four additional SUT (Single Use Technologies) Cleanrooms that will allow Foxx to meet the high demands of their biotechnology and biopharmaceutical customers. New... - August 04, 2021 - Foxx Life Sciences
HCS Pharma Secures 20 Million EUR Capital Commitment from the GEM Group for the Development of BIOMIMESYS® Products
HCS Pharma announced today that it has signed an agreement with GEM Global Yield LLC SCS ("GEM") a Luxemburg-based private alternative investment group for a EUR 20 million capital commitment. - August 04, 2021 - HCS Pharma
The Cause of Nearsightedness is Explained for the First Time; Work at MIT and Multivision Research Leads to Dr. Medina's Conclusion That Lenses Are the Cause of Myopia
The cause of myopia (nearsightedness) has been unveiled in the article: “The cause of myopia development and progression: Theory, evidence, and treatment” available online as an article-in-press in the scientific journal Survey of Ophthalmology on July 28, 2021. - August 01, 2021 - Antonio Medina
ConSep II™ Filter Module, a Game Changer in Fermentation and High Temperature Cross Flow Filtration Applications
The combination of the patented open channel design and the high temperature capabilities of the ConSep II™ filter module provide unique performance characteristics which customers describe as an "enabling technology" and "a game changer." - July 29, 2021 - SmartFlow Technologies
NuvOx Pharma Receives FDA Allowance to Proceed with Phase II Clinical Trial of NanO2TM in Ischemic Stroke
NuvOx Pharma, a Tucson-based biopharmaceutical company, has received notice from the FDA that they may proceed with a Phase II clinical trial of their drug, NanO2TM, in ischemic stroke. Stroke affects nearly 800,000 patients each year in the US. It is the fourth leading cause of death in this... - July 29, 2021 - NuvOx Therapeutics
Malaysia Thailand Collaboration to Increase the Affordability and Accessibility of Cancer Drugs in Thailand Through Local Manufacturing
Strategic collaboration between Malaysia and Thailand has been announced for technology and knowledge transfer to develop R&D and manufacturing of prescription drugs in the initiative to help millions of cancer patients in ASEAN region. - July 28, 2021 - Oncogen Pharma (Malaysia) Sdn Bhd
NuvOx Pharma Announces Issuance of New Patent Covering a New Method of Treating Cancer Utilizing Lead Drug Candidate NanO2TM
NuvOx Pharma, a privately-held clinical-stage biotechnology company based in Tucson, Arizona, has further expanded its patent portfolio in oxygen therapeutics with the issuance of US Patent No. 10946097, “Fractionated radiotherapy and chemotherapy with an oxygen therapeutic,” describing... - July 23, 2021 - NuvOx Therapeutics
Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute (NHLBI)
Microvascular Therapeutics (MVT) has received funds from the from the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health for its program to treat cardiovascular disease, which kills more Americans than any other disease. As a leader in fluorocarbon... - July 19, 2021 - Microvascular Therapeutics, Inc.
Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase I/II Universal Viral Vaccine Clinical Trial (ALLOPRIME) in Healthy Adults Over 65 Years Old
Mirror Biologics, Inc, (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ vaccines for cancer and infectious diseases where the active... - July 14, 2021 - Mirror Biologics, Inc.
Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase IIB Clinical Trial (STIMVAX) in Patients with Metastatic Colorectal Cancer
Mirror Biologics, Inc. (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ cancer vaccines in which the active ingredients are living... - July 09, 2021 - Mirror Biologics, Inc.
Vedic Lifesciences Predicts Expansion of the Joint Health Market - Consumer Interest in "Science-Backed" Supplements Skyrocketed During the Pandemic
Vedic Lifesciences, a food supplement CRO, announced earlier this week that they have been recruiting for joint health studies like never before. “Joint health studies always contributed about 15% to our overall business. However, this year is something different. We can safely say that claim substantiation studies for joint and bone health supplements are here to stay,” Jayesh Chaudhary, CEO, said. - July 07, 2021 - Vedic Lifesciences
Parvus Therapeutics Announces CEO, Senior Executive, and Board of Directors Appointments
Appoints CEO, Senior Executive, and Board of Directors: Peter M. Strumph, Chief Executive Officer; Brendan Classon PhD, Executive Vice President, Research and Development; Louis Demers, Vice President of Technical Operations; Matthew J. Hogan, member of the Board of Directors - July 06, 2021 - Parvus Therapeutics U.S., Inc.
Survey Report: Conversational Analytics Industry Best Practices
Macrosoft conducted an industry best practices survey during the first two weeks of March 2021. 569 individuals participated in the 20-question survey. - July 03, 2021 - Macrosoft Inc.
Defined Bioscience Launches with $1.5M SBIR from the NIH to Advance Stem Cell Media
Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. - July 03, 2021 - Defined Bioscience Inc.
Pepex Biomedical Receives Approval on a Series of Critical New Patents
Worldwide approval grants the Company exclusivity on a number of methods and manufacturing processes associated with its novel electrochemical biosensors. - July 01, 2021 - Pepex Biomedical, Inc.
Pennsylvania Institute of Technology Names Senior Executive the College's Eleventh President
Trustees of Pennsylvania Institute of Technology, an independent college in Greater Philadelphia, has selected its next President. - June 30, 2021 - Pennsylvania Institute of Technology
Delaware County’s Pennsylvania Institute of Technology (P.I.T.) Awarded $25,000 to Bring Ultrasound Training to Delaware County
Pennsylvania Institute of Technology (P.I.T.), a leader in medical career training was awarded $25,000 by The McLean Contributionship for the acquisition of equipment to launch a two-year degree in Diagnostic Medical Sonography. P.I.T. will be the first college in Delaware County to offer the region an opportunity to train to become an Ultrasound Technician at the two-year level. - June 28, 2021 - Pennsylvania Institute of Technology
GRG Announces 2021 Regenerative Medicine Congress in Dubai UAE
The 2nd Global Regenerative Medicine Congress will be held in Dubai 9-11 September 2021. Registration is now open. Global Regenerative Academy is a world-renowned medical society scientifically studying the clinical application of biological products in the human body. Regenerative Medicine treatments using biological products have been used to slow down the natural aging process, treat a variety of pathologies and improve the quality of life of patients. - June 28, 2021 - Global Regenerative Group
OC Wellness Solutions Releases 4th of July "Happy Pet" CBD Bundle
OC Wellness Solutions releases a 4th of July calming CBD Pet Bundle to help pets deal with the stress of fireworks over the upcoming weeks. - June 25, 2021 - OC Wellness Solutions
Paras Biopharmaceuticals Finland Oy Named as One of the Top Pharma Outsourcing Companies in Europe 2021
Paras Biopharmaceuticals Highlights Company Innovations that Decode and Create Biologics Medicines for Unmet Medical Needs (Pharma Tech Outlook, USA) - June 22, 2021 - Paras Biopharmaceuticals Finland Oy
Targeted Pharmaceuticals and George Mason University Announce First-Ever Preclinical Study Using Cannabinoids in an Organoid Model
Study Examines the Effects of Cannabinoids Treating Central Nervous System (CNS) Viruses including HIV Associated Dementia - June 16, 2021 - Targeted Pharmaceuticals
GENINVO Launches Updated New Website
After months of hard work and dedication, GENINVO is pleased to announce the new and updated website launch. The primary goal of the redesign process was to create a user-focused design, add improved functionality, and provide easy access to information about GENINVO’s products and services. - June 14, 2021 - GenInvo, Inc.
Locus Performance Ingredients Launches Amphi™ M: The Next Generation of Biosurfactants for Household and Industrial Formulations
TSCA-approved sophorolipid is customized to offer safe, green replacements to legacy surfactants with unmatched efficacy. - June 11, 2021 - Locus Performance Ingredients
Updated Creative Biolabs Scholarship Program Specialized for Students in Sciences
Lately, Creative Biolabs released its scholarship program for the year 2021. As an expert biotechnology CRO specialized in the field of antibody production and engineering, Creative Biolabs is always willing to support young and ambitious talents in the medical and science-related fields. The 2021... - June 10, 2021 - Creative Biolabs
PharmAbbie, Inc. Announces the Launch of a Reg D-506(c) Common Stock Offering
PharmAbbie, Inc. is pleased to announce today that it will offer up to 3,191,489 shares of its Class D Common Stock at an offering price of $4.70 per share for an aggregate offering amount of $15,000,000. The shares will be offered to accredited investors only pursuant to Regulation D, Rule 506(c)... - June 09, 2021 - PharmAbbie, Inc.
Rivkin Center Hires Molly O’Connor as Incoming Executive Director
The Rivkin Center, a Seattle-based nonprofit working to improve women’s health by helping them prevent, detect early and survive ovarian and breast cancer, has hired Molly O’Connor to lead the organization upon the retirement of the current executive director. - June 09, 2021 - Rivkin Center
Canada’s Leader in Cannabis Genetics Enters Medical Market
Apollo Green, Canada’s leader in cannabis genetics, announced its entry into the medical marijuana sales with unique strains of cannabis not commonly available in the Canadian marketplace. The importance of having available alternatives for pain management cannot be understated. Studies have recently shown the link between cannabis availability and reduced use of opioids. Three specialty strains of plants and seven strains of seeds will be available in Ontario, Canada. - June 08, 2021 - Apollo Green
Vedic Lifesciences Injects Speed, Transparency Into Studies Despite the Pandemic - Weight Loss and Sports Supplement Companies Continue to Invest in Clinical Trials
Reports across North America and the EU have documented the multifactorial braking effect the COVID-19 pandemic has had on the momentum of clinical trials. In the same period of about a year, Vedic Lifesciences, a leading contract research organization (CRO) based in India, reports increased interest from dietary supplement companies in the of weight management and sports nutrition categories. - June 08, 2021 - Vedic Lifesciences
Illyasha Peete Named Executive Director of CLS Racial and Social Equity Initiative
Will Lead Organizational Focus on Addressing Racial & Social Equity within Life Sciences Industry. - June 07, 2021 - California Life Sciences
MedSend and On-Belay Partner to Train African Orthopedic Surgeons
On-Belay Medical and MedSend jointly announce their partnership in training national orthopedic surgeons in Africa. On-Belay Medical has committed $125,000 towards MedSend’s five-year residency programs for training national orthopedic surgeons. On-Belay is an innovative medical device... - June 04, 2021 - MedSend
Customer Communications Management (CCM) Best Practices Technology Survey Results
Macrosoft conducted a Customer Communications Management (CCM) best practices survey during March 2021. 584 people participated in the 21-question on-line survey. Survey results show an industry in flux, with sharp opinion differences concerning the role of CCM applications in the present technology world. - June 04, 2021 - Macrosoft Inc.
California’s Most Impactful Life Sciences Trade Group Reveals New Brand Reflecting Unique Identity
The “Association” and “Institute” will become “California Life Sciences” to better reflect the ecosystem it represents. - June 03, 2021 - California Life Sciences
Thrivous Launches Omega Cardioprotector Formula 2
Thrivous, the human enhancement company, has released Omega Cardioprotector Formula 2. Omega is an advanced geroprotector supplement that Thrivous develops to enhance heart function and circulation for better aging. Omega formula 2 combines geroprotector nutrients with the highest levels of... - June 03, 2021 - Thrivous
ALS TDI Launches New Young Faces of ALS Program
The ALS Therapy Development Institute's Young Faces of ALS program spreads awareness about the impact that ALS can have on young people; launch coincides with MLB's inaugural Lou Gehrig Day. - June 02, 2021 - ALS Therapy Development Institute
Blue Prism Honors QualityKiosk Technologies as an Award Winner at Partner Forum 2021
Key Blue Prism partner QualityKiosk Technologies acknowledged for helping enterprise customers drive digital transformation via Blue Prism’s digital workforce. - June 02, 2021 - QualityKiosk Technologies Pvt. Ltd.
High Ground Medica Initiates Process to Secure LOI with Malta Enterprise as First Step Towards EU-GMP Certification; Announces Growth Financing
· Securing a Letter of intent is the first step to obtain a cannabis processing license in Malta. · Upon securing the LOI, High Ground will sign a lease on an identified facility that will be developed to EU-GMP certified standards. · The EU-GMP certified facility will serve as... - June 01, 2021 - High Ground
MADSA Joins MAREA
The Malaysian Dietary Supplement Association joins the Malaysian Recycling Alliance to assist Members to play a more meaningful role in ESG and SDG to save the planet. - May 27, 2021 - Malaysian Dietary Supplement Association
ICIS Names Locus Performance Ingredients Top Newcomer in the World Surfactants Awards for Biosurfactant Innovations
Company is praised for proprietary fermentation technology that produces high-purity, zero-carbon sophorolipids with maximized performance and sustainability. - May 27, 2021 - Locus Performance Ingredients
Survey Report: Visual FoxPro Technology Best Practices in 2021
Macrosoft Inc. conducted an industry best practices survey during March 2021. 366 individuals participated in the 21-question on-line survey. Based on the broad participation it is believed that the results are highly accurate and represent a significant portion of the industry. - May 27, 2021 - Macrosoft Inc.
Solaris Chem Expands Its Distributors Network
Solaris Chem is a company working in the field of fine organic chemistry, synthesizing materials for the organic electronic industry since 2007. His R&D program is mainly focused on the synthesis of custom made semi-conducting polymers, fullerene derivatives and dyes specially formulated for... - May 26, 2021 - Solaris Chem Inc.
Updated Findings of COVID-19 Impact on Biopharmaceutical Industry & CRO Outsourcing Report
2021 Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing and Changes Since 2020 - May 25, 2021 - Life Science Strategy Group, LLC
Chicago Leading the Way: New Educational Collaboration Seeks to Create a Clinical Action Plan to Eradicate Racial Disparity Gap in Breast Cancer
Improving clinical practice and health outcomes for all patients through education. - May 20, 2021 - ACHL